ADC Deal-Making: Will Success Lead to More Success?

Time: 2:10 pm
day: Conference Day Two

Details:

  • Discussing opportunity for and examples of creative deal structures across ADCs 
  • For payloads: Do you need the full ADC payload for a deal?
  • For linkers: What drives deals with different types of linkers? 
  • For target discovery: What are the differences in deal structure versus linkers and payloads?
  • Sharing guidance to progress from a research collaboration to a licensing agreement, and deal structure including direction for upfront milestones and royalties

Speakers:

John Mayfield John joined Flagship Pioneering in 2024 as Senior Vice President of Business Development & Strategy. In this role, John leverages his expertise in licensing, transactions, Read more
Bob Lutz Bob is the CSOof Iksuda Therapeutics, after being Vice President of Tanslational R&D at ImmunoGen. Whilst at ImmunoGen, Bob was directly responsible for the development Read more
Filippo Mulinacci Filippo holds a MSc in Chemistry from University of Turin in Italy, a PhD in Sciences from the School of Pharmacy of the University of Read more
Tim Wang Mr Wang, CFA, is Chief Business Officer of Duality Biologics. From October 1997 to December 2002, Mr. Wang worked in drug research and development at Read more
Matthew Metzger Matthew joined Oxford Biotherapeutics in 2022 and has since been dedicated primarily to external innovation, coordinating and delivering target validation data for partnership programs and Read more
Barbara Leyman Barbara joined Sutro in 2024 and she brought 20 years of deal making experience in life sciences to the company. Prior to Sutro, she worked Read more